Emerson Dawn M, Chen Stephen Cl, Kelly Melani R, Parnell Bryant, Torres-McGehee Toni M
Department of Health, Sport, and Exercise Sciences, University of Kansas, KS, 66045, USA.
Division of Exercise and Sport Science, Bob Jones University, SC, 29614, USA.
J Exerc Sci Fit. 2021 Apr;19(2):127-133. doi: 10.1016/j.jesf.2020.12.003. Epub 2021 Jan 6.
Because of their anti-pyretic effects, some individuals prophylactically use non-steroidal anti-inflammatory drugs (NSAIDs) to blunt core temperature (Tc) increases during exercise, thus, potentially improving performance by preventing hyperthermia and/or exertional heat illness. However, NSAIDs induce gastrointestinal damage, alter renal function, and decrease cardiovascular function, which could compromise thermoregulation and increase Tc. The aim of this systematic review was to evaluate the effects of NSAIDs on Tc in exercising, adult humans.
We conducted searches in MEDLINE, PubMed, Cochrane Reviews, and Google Scholar for literature published up to November 2020. We conducted a quality assessment review using the Physiotherapy Evidence Database scale. Nine articles achieved a score ≥ seven to be included in the review.
Seven studies found aspirin, ibuprofen, and naproxen had no effect (p > .05) on Tc during walking, running, or cycling for ≤ 90 min in moderate to hot environments. Two studies found significant Tc changes. In one investigation, 81 mg of aspirin for 7-10 days prior to exercise significantly increased Tc during cycling (p < .001); final Tc at the end of exercise = 38.3 ± 0.1 °C vs. control = 38.1 ± 0.1 °C. In contrast, participants administered 50 mg rofecoxib for 6 days experienced significantly lower Tc during 45 min of cycling compared to placebo (NSAID Tc range ≈ 36.7-37.2 °C vs control ≈ 37.3-37.8 °C, p < 0.05).
There are limited quality studies examining NSAID effects on Tc during exercise in humans. The majority suggest taking non-selective NSAIDs (e.g., aspirin) 1-14 days before exercise does not significantly affect Tc during exercise. However, it remains unclear whether Tc increases, decreases, or does not change during exercise with other NSAID drug types (e.g., naproxen), higher dosages, chronic use, greater exercise intensity, and/or greater environmental temperatures.
由于具有解热作用,一些人预防性地使用非甾体抗炎药(NSAIDs)来抑制运动期间核心体温(Tc)的升高,从而有可能通过预防体温过高和/或运动性热疾病来提高运动表现。然而,NSAIDs会导致胃肠道损伤、改变肾功能并降低心血管功能,这可能会损害体温调节并使Tc升高。本系统评价的目的是评估NSAIDs对成年运动人群Tc的影响。
我们在MEDLINE、PubMed、Cochrane系统评价和谷歌学术中检索截至2020年11月发表的文献。我们使用物理治疗证据数据库量表进行质量评估。9篇文章得分≥7分被纳入本评价。
7项研究发现,在中度至炎热环境中步行、跑步或骑行≤90分钟期间,阿司匹林、布洛芬和萘普生对Tc没有影响(p>0.05)。2项研究发现Tc有显著变化。在一项调查中,运动前7 - 10天服用81毫克阿司匹林会使骑行期间的Tc显著升高(p<0.001);运动结束时的最终Tc = 38.3±0.1°C,而对照组为38.1±0.1°C。相比之下,与安慰剂相比,服用50毫克罗非昔布6天的参与者在45分钟的骑行期间Tc显著更低(NSAIDs组Tc范围约为36.7 - 37.2°C,对照组约为37.3 - 37.8°C,p<0.05)。
关于NSAIDs对人类运动期间Tc影响的高质量研究有限。大多数研究表明,运动前1 - 14天服用非选择性NSAIDs(如阿司匹林)对运动期间的Tc没有显著影响。然而,在使用其他NSAIDs药物类型(如萘普生)、更高剂量、长期使用、更大运动强度和/或更高环境温度的运动过程中,Tc是升高、降低还是不变仍不清楚。